Metformin sensitizes lung cancer cells to treatment by the tyrosine kinase inhibitor erlotinib.
Wang X, Chen K, Yu Y, Xiang Y, Kim JH, Gong W, Huang J, Shi G, Li Q, Zhou M, Sayers T, Tewary P, Gao B, Wang JM.
Wang X, et al. Among authors: yu y.
Oncotarget. 2017 Nov 21;8(65):109068-109078. doi: 10.18632/oncotarget.22596. eCollection 2017 Dec 12.
Oncotarget. 2017.
PMID: 29312591
Free PMC article.